Skip to main
  1. Stocks
  2. Colgate-Palmolive
  3. Forecast
CL

Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive (CL) Analyst Ratings

Based on 16 analyst ratings
Buy
Strong Buy 31%
Buy 38%
Hold 31%
Sell 0%
Strong Sell 0%

Bulls say

Colgate-Palmolive is supported by a high-quality global portfolio, with international sales near 70% of revenue, nearly half from emerging markets, and Hill’s contributing almost one-fourth of sales through premium pet nutrition channels. Recent results strengthened the bull case: organic sales grew 3.6% on 5.4% emerging-market growth, while operating leverage from 1.7% volume/mix lifted gross margin and EPS, prompting a 2026 EPS forecast of 6% growth and gross margin of 60.4%. The outlook remains constructive because productivity and pricing are offsetting roughly $300M in raw-material headwinds, and management sees early share improvement in North America alongside continued strength in emerging markets and Hill’s.

Bears say

Colgate-Palmolive is facing a negative outlook because its North America business remains a growth drag, with Q3 organic sales down 1.6%, volumes down 3%, and operating margin falling 210 bps to 19.5%, the worst of any division. Competitive pressure from P&G and Haleon, combined with self-inflicted pricing and promotion missteps, has exposed innovation gaps in whitening and premium therapeutics, while Colgate Total’s 2025 relaunch appears late relative to rivals’ entrenched positions. At the same time, management expects commodity, logistics, and FX headwinds to persist into next year and through 1H27, limiting margin durability even after 90 bps of Q3 gross margin expansion.

Colgate-Palmolive (CL) has been analyzed by 16 analysts, with a consensus rating of Buy. 31% of analysts recommend a Strong Buy, 38% recommend Buy, 31% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Colgate-Palmolive and is not a guaranteed prediction by Public.com or investment advice.

Colgate-Palmolive (CL) Analyst Forecast & Price Prediction

Get the latest Colgate-Palmolive (CL) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Colgate-Palmolive (CL)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Colgate-Palmolive (CL) Forecast

Analysts have given Colgate-Palmolive (CL) a Buy based on their latest research and market trends.

According to 16 analysts, Colgate-Palmolive (CL) has a Buy consensus rating as of Nov 6, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $101.31, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $101.31, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Colgate-Palmolive (CL)


Colgate-Palmolive (CL) Analyst Forecast & Price Prediction

Get the latest Colgate-Palmolive (CL) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Colgate-Palmolive (CL)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover CL stock data and trends